SEE
40
3
DHR
57
-9
EXR
51
-2
WDC
37
-13
LNC
58
3
THC
73
3
VMC
68
5
AON
56
2
NTRS
52
3
PEP
48
4
EFX
77
2
SYF
57
-12
CLX
51
2
KEY
70
3
MHK
55
7
DAL
42
2
CCL
54
-6
CMA
56
6
FAST
57
5
CSX
48
2
SEE
40
3
DHR
57
-9
EXR
51
-2
WDC
37
-13
LNC
58
3
THC
73
3
VMC
68
5
AON
56
2
NTRS
52
3
PEP
48
4
EFX
77
2
SYF
57
-12
CLX
51
2
KEY
70
3
MHK
55
7
DAL
42
2
CCL
54
-6
CMA
56
6
FAST
57
5
CSX
48
2
Financhill
Back

Immunovant Stock Predictions

Free presentation on how to trade options for overnight gains

Get the free overnight options training here.
Sell
45

IMVT
Immunovant

Last Price:
29.10
Seasonality Move:
45.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Wall Street's Worst Nightmare: Small Town Trader's AI Edge

See the AI advantage for everyday Americans.

Immunovant Stock Forecast

  • Over the next 52 weeks, Immunovant has on average historically risen by 93.7% based on the past 5 years of stock performance.
  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is Immunovant Stock Undervalued?
    The current Immunovant [IMVT] share price is $27.80. The Score for IMVT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • IMVT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Immunovant Stock Go Up Next Year?

  • Over the next 52 weeks, Immunovant has on average historically risen by 93.7% based on the past 5 years of stock performance.

Immunovant Stock Rating

Sell
45
Immunovant (IMVT) is a Sell

Is Immunovant overpriced?

  • Immunovant has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

Immunovant Stock Price History

Is IMVT stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMVT is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunovant.com

52-Week Data

52-Week High:
45.58
52-Week Low:
18.82

Prediction Charts

Market Cap:
4.06B
Price in USD:
27.80
Volume:
1.63M
Beta:
0.72

Technical Analysis

SMA50:
27.85
SMA100:
29.15
SMA200:
33.38
52-Wk Change:
27.82%

Stock Predictions

  • Is Immunovant stock public?
    Yes, Immunovant is a publicly traded company.
  • What is the Immunovant stock quote today?
    The Immunovant stock price is 27.80 USD today.
  • How to buy Immunovant stock online?
    You can buy Immunovant shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-8 27.12 27.65 27.84 26.74
Jul-9 27.57 29.70 29.71 27.43
Jul-10 30.10 30.35 30.48 29.65
Jul-11 30.89 30.34 32.00 29.97
Jul-12 30.88 30.57 30.88 30.03
Jul-15 30.77 30.51 31.07 30.07
Jul-16 30.82 30.92 31.36 30.28
Jul-17 30.49 29.98 30.86 29.30
Jul-18 29.95 28.41 29.95 28.06
Jul-19 28.47 27.97 28.88 27.78
Jul-22 28.19 28.00 28.81 27.78
Jul-23 27.81 27.99 28.34 26.50
Jul-24 27.97 27.94 28.61 27.28
Jul-25 28.13 27.80 28.50 27.37

Immunovant Earnings

Immunovant Earnings Report: Per Share Immunovant Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunovant Forecast Revenue Growth

Immunovant Stock Analysis: Historical quarterly revenues per share for Immunovant and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.34 per share.

* Immunovant stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.